Cavell, a digital health startup based in Ghent’s Wintercircus, announces that it has raised €1.5 million in a pre-seed funding round. With this investment, the company brings several strategic investors on board to accelerate growth in Belgium and across Europe, both in primary and secondary care.
Cavell was founded about a year ago by Anthony Rathé, Pieter Olivier, and Louis Verdonckt to tackle one of the biggest pain points in healthcare: administrative overload and poor medical data quality. Pieter, a neurologist at AZ Sint-Lucas and co-founder, saw the need first hand every day:"As a physician, I noticed how much time was lost to reporting and admin. It was frustrating to see how much that took away from real patient care." That’s why the three created Cavell. The software listens during consultations, surgeries, or nurse rounds, and automatically generates a medical report — coded when necessary — that goes straight into the patient’s file.
Today, Cavell is already delivering a clear impact on the ground. This is confirmed by several hospitals and GP practices where Cavell is now in use.
With the funding, the Cavell team aims to further develop the company into the standard for capturing, structuring, and processing medical data — in every clinical setting, for every user. The focus is on building reliable, scalable technology that fits seamlessly into the daily reality of healthcare providers and integrates perfectly with existing software systems. "Our goal isn’t just to be a digital health tool," says Anthony, co-founder. “We’re building technology that truly works for people in healthcare — robust, user-friendly, and integrated. Only then can we make a lasting difference.”
The capital will also support Cavell’s international rollout. Co-founder Louis Verdonckt sees the funding as a key milestone: "Several promising partnerships are in the pipeline to bring Cavell to many healthcare providers in Belgium. But our ambition goes beyond Belgium — we want to improve healthcare across Europe. Thanks to the trust of our investors, we can now scale faster and increase our impact. We’re incredibly excited to keep building a care system that truly revolves around the patient."